Evaluation of Gaseous Pollutants Emission Rate from Marvdasht Landfills
暂无分享,去创建一个
Amirreza Talaiekhozani | Bahman Masomi | Seyed Mohammad Javad Hashemi | Amirreza Talaiekhozani | S. Hashemi | Bahman Masomi
[1] Jaakko Tuomilehto,et al. Cerebrolysin in Patients With Acute Ischemic Stroke in Asia: Results of a Double-Blind, Placebo-Controlled Randomized Trial , 2012, Stroke.
[2] E. Galloni,et al. Temporal profile of serum anti-inflammatory and pro-inflammatory interleukins in acute ischemic stroke patients , 2001, Neurological Sciences.
[3] Chunhua Zhu,et al. Parthenolide Is Neuroprotective in Rat Experimental Stroke Model: Downregulating NF-κB, Phospho-p38MAPK, and Caspase-1 and Ameliorating BBB Permeability , 2013, Mediators of inflammation.
[4] R. Rodrigo,et al. Oxidative stress and pathophysiology of ischemic stroke: novel therapeutic opportunities. , 2013, CNS & neurological disorders drug targets.
[5] Mohammad Torabi-Nami,et al. Flow Augmentation in Acute Ischemic Stroke , 2016, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[6] Liming Dong,et al. The Neuroprotective Effects of Coccomyxa Gloeobotrydiformis on the Ischemic Stroke in a Rat Model , 2013, International journal of biological sciences.
[7] G. Ladurner,et al. Neuroprotective treatment with Cerebrolysin in patients with acute stroke: a randomised controlled trial , 2005, Journal of Neural Transmission.
[8] Elisabetta Coppi,et al. Mapping Early Changes of Cortical Motor Output after Subcortical Stroke: A Transcranial Magnetic Stimulation Study , 2013, Brain Stimulation.
[9] Zsolt Garami,et al. Site of Arterial Occlusion Identified by Transcranial Doppler Predicts the Response to Intravenous Thrombolysis for Stroke , 2007, Stroke.
[10] E. Rüther,et al. Efficacy of the peptidergic nootropic drug cerebrolysin in patients with senile dementia of the Alzheimer type (SDAT). , 1994, Pharmacopsychiatry.
[11] Wusheng Zhu,et al. Decreased serum brain-derived neurotrophic factor (BDNF) is associated with post-stroke depression but not with BDNF gene Val66Met polymorphism , 2011, Clinical chemistry and laboratory medicine.
[12] H. L. Lutsep,et al. Neurologic safety event rates in the SENTIS trial control population , 2013, Acta neurologica Scandinavica.
[13] Ki Yong Lee,et al. Safety and Efficacy Evaluation of Carnosine, an Endogenous Neuroprotective Agent for Ischemic Stroke , 2013, Stroke.
[14] Jian Guo,et al. Cerebrolysin for vascular dementia. , 2013, The Cochrane database of systematic reviews.
[15] Yanling Hu,et al. The Role of TNF-&agr; 308G>A Polymorphism in the Risk for Ischemic Stroke , 2013, The American journal of the medical sciences.
[16] A. Rabinstein,et al. Collateral Flow Predicts Response to Endovascular Therapy for Acute Ischemic Stroke , 2011 .
[17] Xunming Ji,et al. Normobaric hyperoxia-based neuroprotective therapies in ischemic stroke , 2013, Medical gas research.
[18] Xi Kuang,et al. Neuroprotective Effect of Kaempferol Glycosides against Brain Injury and Neuroinflammation by Inhibiting the Activation of NF-κB and STAT3 in Transient Focal Stroke , 2013, PloS one.
[19] Jian Zhang,et al. Neuroprotective effect of bicyclol in rat ischemic stroke: Down-regulates TLR4, TLR9, TRAF6, NF-κB, MMP-9 and up-regulates claudin-5 expression , 2013, Brain Research.
[20] V Hochstein-Mintzel,et al. [There will exist no interdependence between bovine leukosis and infectious bovine rhinotracheitis]. , 1986, Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B.
[21] Bin Lin,et al. Targeting Oxidative Stress Injury after Ischemic Stroke in Conscious Rats: Limited Benefits with Apocynin Highlight the Need to Incorporate Long Term Recovery , 2013, Stroke research and treatment.
[22] Sombat Muengtaweepongsa,et al. Chinese Medicine Neuroaid Efficacy on Stroke Recovery: A Double-Blind, Placebo-Controlled, Randomized Study , 2013, Stroke.
[23] K. Hossmann. Pathophysiology and Therapy of Experimental Stroke , 2006, Cellular and Molecular Neurobiology.
[24] R. Uflacker,et al. Interim report of the SENTIS trial: cerebral perfusion augmentation via partial aortic occlusion in acute ischemic stroke. , 2008, The Journal of cardiovascular surgery.
[25] D. Liebeskind. Collateral circulation. , 2003, Stroke.
[26] M. Dennis,et al. A systematic review of the effectiveness, cost-effectiveness and barriers to implementation of thrombolytic and neuroprotective therapy for acute ischaemic stroke in the NHS. , 2002, Health technology assessment.
[27] Farzaneh Vafaee,et al. Neuroprotective effects of the immunomodulatory drug Setarud on cerebral ischemia in male rats★ , 2012, Neural regeneration research.
[28] Jieli Chen,et al. Neuroprotective Effect of Human Placenta-Derived Cell Treatment of Stroke in Rats , 2013, Cell transplantation.
[29] Juliana Marisol Godinez Rubi,et al. Nitric oxide donors as neuroprotective agents after an ischemic stroke-related inflammatory reaction , 2018 .
[30] Razia Khanam,et al. Neuroprotective effects of chloroform and petroleum ether extracts of Nigella sativa seeds in stroke model of rat , 2013, Journal of pharmacy & bioallied sciences.
[31] Silvia Manzanero,et al. Neuronal oxidative stress in acute ischemic stroke: Sources and contribution to cell injury , 2013, Neurochemistry International.
[32] R Gupta,et al. Reduced Mortality and Severe Disability Rates in the SENTIS Trial , 2013, American Journal of Neuroradiology.
[33] Yoash Chassidim,et al. Stimulation of the Sphenopalatine Ganglion Induces Reperfusion and Blood-Brain Barrier Protection in the Photothrombotic Stroke Model , 2012, PloS one.
[34] V. Hochstein-Mintzel,et al. No existiría interdependencia entre Leucosis bovina y Rinotraqueitis infecciosa bovina , 1986 .
[35] Narayanaswamy Venketasubramanian,et al. Effects of MLC 601 on Early Vascular Events in Patients After Stroke : The CHIMES , 2013 .
[36] I. Winship,et al. Augmenting Collateral Blood Flow during Ischemic Stroke via Transient Aortic Occlusion , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[37] Ken Butcher,et al. Collateral blood vessels in acute ischaemic stroke: a potential therapeutic target , 2011, The Lancet Neurology.
[38] W. Heiss,et al. Partial Occlusion of the Descending Aorta Increases Cerebral Blood Flow in a Nonstroke Porcine Model , 2009, Cerebrovascular Diseases.
[39] R. Kooijman,et al. Neuroprotective efficacy of subcutaneous insulin-like growth factor-I administration in normotensive and hypertensive rats with an ischemic stroke , 2013, Neuroscience.
[40] Reza Bavarsad shahripour,et al. A Randomized trial to assess the long-term safety of NeuroAiD among Caucasian patients with acute ischemic stroke , 2014, Chinese Journal of Integrative Medicine.
[41] David S Liebeskind,et al. Importance of proper patient selection and endpoint selection in evaluation of new therapies in acute stroke: further analysis of the SENTIS trial , 2013, Journal of NeuroInterventional Surgery.
[42] T. Abbruscato,et al. The role of blood-brain barrier transporters in pathophysiology and pharmacotherapy of stroke. , 2014, Current pharmaceutical design.
[43] Carlos Molina,et al. Effects of Age on Outcome in the SENTIS Trial: Better Outcomes in Elderly Patients , 2012, Cerebrovascular Diseases.
[44] Marco Cursi,et al. Safety and Efficacy of Transcranial Direct Current Stimulation in Acute Experimental Ischemic Stroke , 2013, Stroke.
[45] M. Lazdunski,et al. NeuroAiD: Properties for Neuroprotection and Neurorepair , 2013, Cerebrovascular Diseases.
[46] Johannes Boltze,et al. Inhalation of Nitric Oxide Prevents Ischemic Brain Damage in Experimental Stroke by Selective Dilatation of Collateral Arterioles , 2012, Circulation research.
[47] M. Shamloo,et al. A Pharmacological Screening Approach for Discovery of Neuroprotective Compounds in Ischemic Stroke , 2013, PloS one.
[48] J. Ulatowski,et al. A Pilot Randomized Trial of Induced Blood Pressure Elevation: Effects on Function and Focal Perfusion in Acute and Subacute Stroke , 2003, Cerebrovascular Diseases.
[49] Ana Latorre,et al. Improvement of the circulatory function partially accounts for the neuroprotective action of the phytoestrogen genistein in experimental ischemic stroke. , 2013, European journal of pharmacology.
[50] D. Mozaffarian,et al. Heart disease and stroke statistics--2014 update: a report from the American Heart Association. , 2014, Circulation.
[51] Mindaugas Pranevicius,et al. Partial aortic occlusion and cerebral venous steal: venous effects of arterial manipulation in acute stroke. , 2011, Stroke.